Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its experimental weight-loss drug candidate next ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

A mum has been left "skint" after forking out nearly £2,500 on weight loss jabs - but says "being skinny is worth the price ...

Novo Nordisk A/S and Eli Lilly & Co, the pharmaceutical giants dominating the global obesity drug market, now face their ...

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...

For reference, Novo Nordisk also offers a highly successful weight loss drug, Wegovy, a GLP-1 receptor agonist.

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...

A new drug called amycretin has shown it can help reduce body weight in two early-phase clinical trials. The drug, which ...

Walmart has agreed to pay $10 million to settle a U.S. Federal Trade Commission civil lawsuit accusing the world's largest ...